93 154 (Ticlopidine Hydrochloride 250 mg)
Pill with imprint 93 154 is White, Elliptical/Oval and has been identified as Ticlopidine Hydrochloride 250 mg. It is supplied by Teva Pharmaceuticals USA.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 93 154
Ticlopidine Hydrochloride
- Imprint
- 93 154
- Strength
- 250 mg
- Color
- White
- Size
- 15.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Platelet aggregation inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA
- Inactive Ingredients
-
butylated hydroxyanisole,
corn starch,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
povidone,
stearic acid,
titanium dioxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00093-0154 (Discontinued) | Teva Pharmaceuticals USA, Inc. |
| 42291-0803 (Discontinued) | AvKare, Inc. |
Related images for "93 154"
More about ticlopidine
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Compare alternatives
- Drug class: platelet aggregation inhibitors
Patient resources
- Other brands
- Ticlid
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.